• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53家族转录因子的共同及独特靶基因。

The common and distinct target genes of the p53 family transcription factors.

作者信息

Harms K, Nozell S, Chen X

机构信息

Department of Cell Biology, University of Alabama at Birmingham, 1918 University Blvd., Birmingham, Alabama 35294, USA.

出版信息

Cell Mol Life Sci. 2004 Apr;61(7-8):822-42. doi: 10.1007/s00018-003-3304-4.

DOI:10.1007/s00018-003-3304-4
PMID:15095006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11138747/
Abstract

p53 is the most commonly mutated gene in human cancer. After activation by cellular stresses such as DNA damage or oncogene activation, p53, a sequence-specific DNA-binding protein, induces the expression of target genes which mediate tumor suppression. Two recently identified p53 homologues, p63 and p73, appear to function similarly to p53, that is, they both activate target gene expression and suppress cell growth when overexpressed; however, the p63 and p73 genes are rarely mutated in human cancer and do not adhere to Knudson's classical model of a tumor suppressor gene. Recently, exciting observations suggest nonoverlapping functions for the family members. Herein, we outline the recent literatures identifying and characterizing both the common and distinct target genes of the p53 family transcription factors in relation to their signaling pathways.

摘要

p53是人类癌症中最常发生突变的基因。在受到诸如DNA损伤或癌基因激活等细胞应激激活后,p53作为一种序列特异性DNA结合蛋白,会诱导介导肿瘤抑制的靶基因表达。最近鉴定出的两个p53同源物p63和p73,似乎与p53功能相似,也就是说,它们在过表达时都会激活靶基因表达并抑制细胞生长;然而,p63和p73基因在人类癌症中很少发生突变,并不符合Knudson经典的肿瘤抑制基因模型。最近,令人兴奋的观察结果表明该家族成员具有非重叠功能。在此,我们概述了近期有关鉴定和表征p53家族转录因子的共同及独特靶基因及其信号通路的文献。

相似文献

1
The common and distinct target genes of the p53 family transcription factors.p53家族转录因子的共同及独特靶基因。
Cell Mol Life Sci. 2004 Apr;61(7-8):822-42. doi: 10.1007/s00018-003-3304-4.
2
The p53/p63/p73 family of transcription factors: overlapping and distinct functions.转录因子p53/p63/p73家族:重叠与独特的功能
J Cell Sci. 2000 May;113 ( Pt 10):1661-70. doi: 10.1242/jcs.113.10.1661.
3
Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domain.p53家族成员对多药耐药基因1(MDR1)转录的差异调节。DNA结合结构域的作用。
J Biol Chem. 2005 Apr 8;280(14):13213-9. doi: 10.1074/jbc.M414646200. Epub 2005 Jan 5.
4
Comparative analysis of p73 and p53 regulation and effector functions.p73与p53调控及效应功能的比较分析
J Cell Biol. 1999 Nov 15;147(4):823-30. doi: 10.1083/jcb.147.4.823.
5
From p63 to p53 across p73.从p63经p73至p53。
FEBS Lett. 2001 Feb 16;490(3):163-70. doi: 10.1016/s0014-5793(01)02119-6.
6
The C terminus of p53 family proteins is a cell fate determinant.p53家族蛋白的C末端是细胞命运的决定因素。
Mol Cell Biol. 2005 Mar;25(5):2014-30. doi: 10.1128/MCB.25.5.2014-2030.2005.
7
The p53 family: same response, different signals?p53家族:相同的反应,不同的信号?
Mol Med Today. 1999 Sep;5(9):387-92. doi: 10.1016/s1357-4310(99)01545-2.
8
Role of p73 in malignancy: tumor suppressor or oncogene?p73在恶性肿瘤中的作用:肿瘤抑制因子还是癌基因?
Cell Death Differ. 2002 Mar;9(3):237-45. doi: 10.1038/sj.cdd.4400995.
9
p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.p53/p63/p73 异构体:协调细胞分化与应激反应的异构体“管弦乐队”
Cell Death Differ. 2006 Jun;13(6):962-72. doi: 10.1038/sj.cdd.4401914.
10
The cell type-specific effect of TAp73 isoforms on the cell cycle and apoptosis.TAp73亚型对细胞周期和细胞凋亡的细胞类型特异性作用。
Cell Mol Biol Lett. 2008;13(3):404-20. doi: 10.2478/s11658-008-0011-z. Epub 2008 Mar 18.

引用本文的文献

1
Iron metabolism in a mouse model of hepatocellular carcinoma.肝细胞癌小鼠模型中的铁代谢
Sci Rep. 2025 Jan 16;15(1):2180. doi: 10.1038/s41598-025-86486-x.
2
Nucleo-cytoplasmic environment modulates spatiotemporal p53 phase separation.核质环境调节p53的时空相分离。
Sci Adv. 2024 Dec 13;10(50):eads0427. doi: 10.1126/sciadv.ads0427. Epub 2024 Dec 11.
3
Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression.阐明指挥链:我们目前对 p53 介导的肿瘤抑制的关键靶基因的理解。
Crit Rev Biochem Mol Biol. 2024 Feb-Apr;59(1-2):128-138. doi: 10.1080/10409238.2024.2344465. Epub 2024 Apr 25.
4
Ninjurin 2, a Cell Adhesion Molecule and a Target of p53, Modulates Wild-Type p53 in Growth Suppression and Mutant p53 in Growth Promotion.神经损伤诱导蛋白2,一种细胞粘附分子及p53的靶点,在生长抑制中调节野生型p53并在生长促进中调节突变型p53。
Cancers (Basel). 2024 Jan 4;16(1):229. doi: 10.3390/cancers16010229.
5
Isoform-specific disruption of the gene reveals a critical role for TAp73γ in tumorigenesis via leptin.特定异构体的破坏揭示了 TAp73γ 通过瘦素在肿瘤发生中的关键作用。
Elife. 2023 Aug 31;12:e82115. doi: 10.7554/eLife.82115.
6
Radiotherapy in bone sarcoma: the quest for better treatment option.骨肉瘤的放射治疗:寻求更好的治疗选择。
BMC Cancer. 2023 Aug 11;23(1):742. doi: 10.1186/s12885-023-11232-3.
7
Metal-Based Anticancer Complexes and p53: How Much Do We Know?金属基抗癌复合物与p53:我们了解多少?
Cancers (Basel). 2023 May 19;15(10):2834. doi: 10.3390/cancers15102834.
8
Soluble Guanylate Cyclase β1 Subunit Represses Human Glioblastoma Growth.可溶性鸟苷酸环化酶β1亚基抑制人胶质母细胞瘤生长。
Cancers (Basel). 2023 Mar 2;15(5):1567. doi: 10.3390/cancers15051567.
9
p73α1, an Isoform of the p73 Tumor Suppressor, Modulates Lipid Metabolism and Cancer Cell Growth via Stearoyl-CoA Desaturase-1.p73α1,p73 肿瘤抑制因子的一种异构体,通过硬脂酰辅酶 A 去饱和酶 1 调节脂代谢和癌细胞生长。
Cells. 2022 Aug 13;11(16):2516. doi: 10.3390/cells11162516.
10
Biallelic and gene-wide genomic substitution for endogenous intron and retroelement mutagenesis in human cells.在人类细胞中进行内源性内含子和反转元件诱变的双等位基因和全基因组置换。
Nat Commun. 2022 Jul 21;13(1):4219. doi: 10.1038/s41467-022-31982-1.

本文引用的文献

1
[Redefinition of myocardial infarction--relevance of biomarkers].[心肌梗死的重新定义——生物标志物的相关性]
Herz. 2008 Mar;33(2):115-21. doi: 10.1007/s00059-008-3103-7.
2
Integrated biomarkers in cardiomyopathies: cardiovascular magnetic resonance imaging combined with molecular and immunologic markers--a stepwise approach for diagnosis and treatment.心肌病中的整合生物标志物:心血管磁共振成像结合分子和免疫标志物——诊断和治疗的逐步方法
Herz. 2007 Sep;32(6):458-72. doi: 10.1007/s00059-007-3046-4.
3
[Pericardiocentesis].[心包穿刺术]
Dtsch Med Wochenschr. 2007 Aug;132(33):1707-10. doi: 10.1055/s-2007-984955.
4
Diagnostic value of the biochemical composition of pericardial effusions in patients undergoing pericardiocentesis.心包穿刺患者心包积液生化成分的诊断价值
Am J Cardiol. 2007 May 1;99(9):1294-7. doi: 10.1016/j.amjcard.2006.12.048. Epub 2007 Mar 19.
5
Magnetic resonance imaging in pericardial diseases. Indications and diagnostic value.心包疾病的磁共振成像。适应证与诊断价值。
Herz. 2006 Oct;31(7):708-14. doi: 10.1007/s00059-006-2894-7.
6
Noninvasive evaluation of pericardial effusion composition by computed tomography.通过计算机断层扫描对心包积液成分进行无创评估。
Am Heart J. 2005 Jun;149(6):1120-7. doi: 10.1016/j.ahj.2004.08.028.
7
The composition of normal pericardial fluid and its implications for diagnosing pericardial effusions.正常心包积液的成分及其对心包积液诊断的意义。
Am J Med. 2005 Jun;118(6):636-40. doi: 10.1016/j.amjmed.2005.01.066.
8
[Natriuretic peptides--new diagnostic markers in heart disease].[利钠肽——心脏病的新型诊断标志物]
Herz. 2004 Sep;29(6):609-17. doi: 10.1007/s00059-004-2619-8.
9
Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa.噻替派心包内化疗治疗恶性心包积液的长期结果
Chest. 2004 Nov;126(5):1412-6. doi: 10.1378/chest.126.5.1412.
10
Cardiovascular magnetic resonance imaging: current and emerging applications.心血管磁共振成像:当前及新兴应用
J Am Coll Cardiol. 2004 Sep 15;44(6):1164-71. doi: 10.1016/j.jacc.2004.06.033.